antipyrine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 2 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It should be taken into account when dosing drugs which are metabolized as markers of the liver metabolic efficiency like phenazone and sulphadimidine." | 2.68 | [Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms]. ( Kotlarek-Haus, S; Milejski, P; Orzechowska-Juzwenko, K; Urbaniak-Kujda, D; Usnarska-Zubkiewicz, L; Wiela-Hojeńska, A, 1997) |
| " The mean phenazone half-life (t0." | 1.27 | Phenazone pharmacokinetics as an index of hepatic metabolic efficiency. ( Kotlarek-Haus, S; Orzechowska-Juzwenko, K; Plamieniak, B; Wiela, A; Wolowiec, D, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wiela-Hojeńska, A | 1 |
| Milejski, P | 1 |
| Orzechowska-Juzwenko, K | 2 |
| Usnarska-Zubkiewicz, L | 1 |
| Urbaniak-Kujda, D | 1 |
| Kotlarek-Haus, S | 2 |
| Wiela, A | 1 |
| Plamieniak, B | 1 |
| Wolowiec, D | 1 |
1 trial available for antipyrine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
[Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms].
Topics: Acetylation; Adolescent; Adult; Aged; Antipyrine; Disease Susceptibility; Female; Hodgkin Disease; H | 1997 |
1 other study available for antipyrine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Phenazone pharmacokinetics as an index of hepatic metabolic efficiency.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antipyrine; Female; Hodgkin Disease; Humans; | 1988 |